US$ 25.54
cjc ipamorelin mechanism 1295 cjc-1295 ipamorelin mechanism efficacy side
Description
Topfer-Petersen E, Calvete JJ

The common feature of leukemia-associated Idh1 and Idh2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

10.1016/j.fertnstert.2003.06.026 105

Cell 83 (7), 10301042

doi: 10.1111/eci.13989
